Lactate supplements and the "strong legs" claim, graded

Do lactate supplements do anything?

Not much, and not the same thing twice. In a simulated road race, perceived effort fell and performance did not move. In a 20-minute time trial, performance rose about 4 percent and perceived effort did not move. Neither of the two modern trials moved both, and the largest result comes from a short severe protocol that resembles no ride.

Lactate supplements are sold on a sensation. The category promise, whether it arrives as a capsule taken before a ride or as a gel squeezed during one, is that your legs will stop screaming so early: less burn, a steadier rhythm, a fourth hour that feels like the second. That promise is unusually testable, because "feels easier" and "goes faster" are measured separately in exercise science and they can be made to disagree.

They disagree here. In the most realistic trial of the modern batch, sixteen endurance-trained male cyclists rode a session built to simulate road racing, and lactate supplementation produced no effect on performance while perceived exertion fell and blood buffering measurably improved[2]. The supplement did something. What it did was not the thing on the label.

That is the shape of this whole field, and it is worth holding onto before any individual study gets quoted at you. Nothing here is fraudulent. Lactate is a real fuel and a real signal, the biochemistry is sound, and the acid-base changes the trials record are genuine. The question a buyer actually has is narrower: does any of it reach the finish line.

Two products, one blurred promise

Two different things share the shelf. Lactate salt capsules are taken before exercise and sold on the language of burning legs. Lactate gels are a newer arrival aimed at fuelling and buffering during long events. They carry different doses, different timing, and separate evidence, and they are routinely discussed as though they were one product.

Ask whether lactate supplements work and the honest first move is to ask which one. The older category is a pre-exercise capsule built on lactate salts, sold for years on the language of heavy or burning legs, and taken in the hour or so before you start. The newer one is the lactate gel that arrived more recently in professional cycling, taken during the event and pitched at fuelling and buffering rather than at a pre-emptive fix.

The trials do not treat them as one thing either, and the doses tell you why. The pre-exercise studies that found something used 120 mg per kilogram of body mass taken well before the test[4], which for an 80 kg rider is close to ten grams in one sitting. That is a large amount of a salt to put into a stomach that is about to be asked to work, and gastrointestinal tolerance turns up as a reported outcome in these papers rather than as a footnote.

Conflating the two categories is how a result migrates. A number generated in a short laboratory test on a pre-exercise capsule ends up quoted in a product page for a gel taken three hours into a race, and the reader has no way to see that the dose, the timing, the protocol and the population have all changed underneath the claim.

What the trials actually measured

Three human trials carry most of the weight, and they disagree in an informative way. The same dose that raised time to exhaustion by 17% in a short severe test produced nothing across a simulated road race. A third trial found a 4% work-rate gain and no change in any threshold, and was funded by a supplement company.

The strongest single number in this field is old and small. Eleven trained cyclists took 120 mg per kilogram of lactate 80 minutes before a high-intensity ride to exhaustion, and time to exhaustion and total work rose by 17% against placebo[4]. Blood bicarbonate (the body's main chemical buffer against acidity) went up, which is the mechanism the result is usually attributed to.

Thirteen years later, sixteen cyclists took the same dose before a session of five repeated blocks of 1 km and 4 km time trials with moderate riding in between, which is a far better model of a race than a ride to exhaustion. Buffering improved again, perceived exertion fell, and performance did not move[2]. Same dose, same molecule, opposite conclusion, and the difference is the protocol rather than the supplement.

The third trial is the one most often cited as a win. A 2024 crossover study gave a commercial lactate supplement at a much smaller 19 mg per kilogram and found no change in peak oxygen uptake, none at the ventilatory threshold, and none in work rate at the lactate threshold[3]. What it did find was a 4% higher work rate across a 20-minute time trial[3]. That is a real result and it is also a modest one, measured in a pilot, on a product whose maker funded the research[3]. None of that makes it wrong. It does mean it is the weakest kind of evidence to hang a category on, and it is the number the category leans on hardest.

Each trial moved one thing, never both

The smoother-legs story is supported by one trial and contradicted by another. In the simulated road race, perceived effort fell while performance stayed flat. In the 20-minute time trial, performance rose about 4 percent while perceived effort did not move at all. Neither trial produced both at once.

This is the part worth being careful with, because it is where the marketing claim and one real result come closest to agreeing. In the simulated road race, perceived exertion dropped on lactate and performance did not[2]. The riders felt better and the clock did not care, which is exactly the product's promise and exactly not its proof.

The trouble is that the other modern trial found the mirror image[3]. In the 20-minute time trial, work rate rose by about 4 percent and perceived exertion did not differ from placebo at all[3]. So across the two, one trial moved the feeling and not the performance, and the other moved the performance and not the feeling. Neither moved both, and the two results point in opposite directions about which one lactate touches.

That is a weaker and more honest picture than either side tends to draw. A rider who takes a lactate capsule and reports smoother legs is describing something one trial measured, so the testimonials are not lies. But feeling better and performing better are not the same purchase, neither of these trials delivered them together, and perceived exertion is a rating a participant gives rather than a number a machine records, which makes it the outcome most sensitive to knowing what you took.

Lactic acid never caused the soreness

The premise under the leg marketing was tested in 1983 and failed. Level running raised blood lactate and produced no soreness. Downhill running produced significant soreness with no rise in lactate. Soreness comes from mechanical damage and the inflammation that follows, on a timeline lactate does not share.

Most of the language this category sells in descends from an idea that was already in trouble forty years ago. The classic experiment measured blood lactic acid across 45 minutes of treadmill running, once on the level and once running downhill[5]. Level running is the condition that raises lactate. Downhill running is the condition that wrecks you two days later.

The results came apart exactly where the theory needed them to hold. Lactate rose on the level and no meaningful soreness followed. Downhill, lactate never climbed and soreness arrived anyway[5]. Delayed onset muscle soreness (the stiffness that peaks a day or two after unfamiliar training) is mechanical damage and inflammation, not an acid that has been sitting in the muscle.

It also does not sit there. Blood lactate returns toward baseline within roughly an hour of stopping, which is a timeline with no overlap at all with soreness that peaks a day or two after the session. A supplement can be worth taking for reasons that have nothing to do with a myth, and lactate salts may well be. But when a product is explained to you using the burn and the next-day ache in the same breath, the explanation is doing marketing rather than physiology.

The muscle-building claim has a human answer

Lactate raises mTORC1 signalling and drives growth in cultured muscle cells, which is where the anabolic claim comes from. When researchers infused lactate into people doing one-legged resistance exercise, signalling and protein synthesis were unchanged. Cell culture said yes and the leg said no.

Alongside the endurance pitch runs a quieter one aimed at lifters: that lactate is an anabolic signal, so raising it should build muscle. The cell biology behind that is genuine. In myotubes (muscle cells grown in a dish), lactate raises mTORC1 and ERK signalling, the pathways that switch on muscle protein synthesis, and produces growth[1]. If you stop reading there, the supplement writes itself.

Somebody tested it in people, and the design is almost too neat for this article. Eight men and eight women performed one-legged resistance exercise while receiving an infusion of either saline or sodium lactate, with muscle biopsies taken out to 24 hours[1]. The infusion worked: blood lactate ran far higher on the lactate arm. The signalling pathways rose after exercise in both arms, as they should, with no difference between them.

The headline outcome is the cleanest number in this post. Fractional synthesis rate, which is how fast muscle protein is actually being built, came out at 0.067%/h on saline and 0.062%/h on lactate[1]. The authors' own conclusion is that the study does not support the hypothesis that blood lactate modulates anabolic signalling in working human muscle[1]. Raising the number in the blood is not the same as delivering the signal inside the cell, and that distinction is where the claim dies.

Where peptides sit in the same logic

Exercise-mimetic peptides run the argument lactate supplements run: find a molecule that exercise produces, supply it directly, and expect the adaptation. Lactate is the cheapest possible test of that logic in humans, and it mostly failed. That is a reason to read the peptide claims with the same question in hand.

Readers here mostly arrive from the peptide side, and the connection is not decorative. Exercise-mimetic peptides such as MOTS-c are built on a specific argument: exercise produces a molecule, that molecule carries part of the adaptation, so supplying the molecule should carry part of the benefit. Lactate is the same argument with a cheaper ingredient and a much longer research record.

The molecular case is also live rather than closed. Lactylation, a chemical tag that lactate leaves on proteins and that can change how genes are read, is an active field[6]. It is worth being precise about how far it has got: the exercise evidence sits largely in rodents, and the human studies that exist are few and mixed[7].

What the human trials add is a distinction that gets lost in the jump from mechanism to product. Lactate made inside a contracting muscle and lactate poured into the bloodstream are not interchangeable, and the one-legged infusion study is the cleanest demonstration of that anyone has run. Where the molecule is made, when, and next to what appears to matter more than how much of it is circulating. Any peptide sold on the same structure of argument deserves the same question, asked in the same order: what did it do in cells, what did it do in animals, and what happened when somebody put it into a person and measured the outcome rather than the pathway.